share_log

Baird Initiates Coverage On Soleno Therapeutics With Outperform Rating, Announces Price Target of $72

Baird Initiates Coverage On Soleno Therapeutics With Outperform Rating, Announces Price Target of $72

貝爾德以跑贏大盤的評級啓動對Soleno Therapeutics的報道,宣佈目標股價爲72美元
Benzinga ·  05/10 17:19

Baird analyst Brian Skorney initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Outperform rating and announces Price Target of $72.

貝爾德分析師布萊恩·斯科尼以跑贏大盤的評級啓動了對索理諾療法(納斯達克股票代碼:SLNO)的報道,並宣佈目標股價爲72美元。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論